The Astellas Institute of Regenerative Medicine (AIRM) is a wholly-owned subsidiary of Astellas Pharma and focused on the development and commercialization of stem cell and regenerative medicine therapies. Astellas is an R&D-driven global pharmaceutical company whose philosophy is to contribute to the improvement of people s heath around the world through the provision of innovative and reliable pharmaceutical products.
Developing innovative therapies is one of the most challenging, most essential and personally rewarding fields in science. This is the most exciting time to be a part of Astellas, a company with a uniquely collaborative and patient-focused culture. There s something special about working at Astellas. It s reflected in our focus on the people we serve, the way we treat each other and the results we achieve together as a company.
AIRM has a world-class R&D team, and is pursuing a diverse range of disease indications, ranging from macular degeneration (currently in clinical trials) and other ocular indications to vascular and autoimmune disease. AIRM s intellectual property portfolio includes pluripotent stem cell platforms - both embryonic and induced pluripotent stem cells as well as other cell based therapy research programs. AIRM is headquartered in Marlborough, Massachusetts.
The Senior Scientist, Retinal Development & Disease will be responsible for preclinical-stage research activities of retinal projects at AIRM. This person will create strategy/plan and execute experiments to develop and implement protocols for cell differentiation and characterization. This person will also be expected to proactively collaborate with others, both within and outside the team, to streamline and accelerate the process development in order to transfer the protocols to technical operations.
Essential Job Responsibilities:
AbbVie - Worcester, MA
AbbVie - Cambridge, MA
Humana - Boston, MA
Quest Diagnostics - Marlborough, MA
Seven Bridges - Boston, MA